Immutep (IMMP) Capital Expenditures (2011 - 2017)

Immutep (IMMP) has reported Capital Expenditures for 4 consecutive years, with $6981.0 the latest figure, recorded in Q2 2017.

• For the quarter ending Q2 2017, Capital Expenditures rose 146.22% year-over-year to $6981.0; the trailing twelve-month figure through Jun 2017 stood at -$55752.8 (changed N/A YoY), and the FY2026 full-year result was -$65920.2, down 124.89% from the prior year.
• Capital Expenditures rose to $6981.0 in Q2 2017 per IMMP's latest filing, from -$15104.3 in the prior quarter.
• Across five years, Capital Expenditures topped out at $6981.0 in Q2 2017 and bottomed at -$15104.3 in Q2 2016.
• Historically, Capital Expenditures has averaged -$2723.4 across 3 years, with a median of -$47.0 in 2015.
• The sharpest annual moves came in 2016 and 2017: Capital Expenditures tumbled 32036.8% in 2016, then jumped 146.22% in 2017.
• Over 3 years, Capital Expenditures stood at -$47.0 in 2015, then sank by 32036.8% to -$15104.3 in 2016, then surged by 146.22% to $6981.0 in 2017.
• According to Business Quant data, Capital Expenditures over the past three periods registered $6981.0, -$15104.3, and -$47.0 for Q2 2017, Q2 2016, and Q2 2015 respectively.